Shandong Weigao (1066) Announces 2026 First EGM and Related Transaction Documents

Bulletin Express01-26

Shandong Weigao Group Medical Polymer Company Limited (Stock Code: 1066) has published details of its 2026 first extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for 12 February 2026 at 9:00 a.m., to be held on the second floor of 1 Weigao Road, Torch Hi-Tech Science Park, Weihai, Shandong Province, People’s Republic of China.

The main agenda of the EGM involves approving, confirming, and ratifying the Sale and Purchase Agreement (comprising the Original Sale and Purchase Agreement and the Supplemental Sale and Purchase Agreement), the Compensation Agreement, and the Letter of Non-Competition Undertakings, all dated 5 January 2026. All transactions contemplated under these agreements are also included for shareholder consideration. Any Director of the company will be authorized to perform any necessary actions and sign relevant documents to implement the transactions upon receiving approval. The circular containing further details is dated 26 January 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment